Kymera Therapeutics

Kymera is pioneering a transformative new approach to treating previously untreatable diseases — targeted protein degradation — accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins and advance new treatment options for patients.

Headquarters Cambridge, MA
Pipeline Preclinical
Twitter @kymeratx​
Partners GSK, Vertex, Sanofi